USFDA completes inspection at Lupin’s Tarapur API facility

23 Sep 2019 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Lupin’s Tarapur manufacturing (API) facility. The inspection was carried out between September 16 to September 20, 2019. The inspection at the Tarapur facility closed with three observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

1617.85 19.65 (1.23%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.